Brekke IB - Search Results

1

A strong impact of matching for a limited number of HLA-DR antigens on graft survival and rejection episodes: a single-center study of first cadaveric kidneys to nonsensitized recipients.

Reisaeter AV, Leivestad T, Vartdal F, Spurkland A, Fauchald P, Brekke IB, Thorsby E. Reisaeter AV, et al. Among authors: brekke ib. Transplantation. 1998 Aug 27;66(4):523-8. doi: 10.1097/00007890-199808270-00018. Transplantation. 1998. PMID: 9734498

2

Individualized T cell monitored administration of ATG versus OKT3 in steroid-resistant kidney graft rejection.

Midtvedt K, Fauchald P, Lien B, Hartmann A, Albrechtsen D, Bjerkely BL, Leivestad T, Brekke IB. Midtvedt K, et al. Among authors: brekke ib. Clin Transplant. 2003 Feb;17(1):69-74. doi: 10.1034/j.1399-0012.2003.02105.x. Clin Transplant. 2003. PMID: 12588325 Clinical Trial.

3

Fifteen years' experience with renal transplantation in systemic amyloidosis.

Hartmann A, Holdaas H, Fauchald P, Nordal KP, Berg KJ, Talseth T, Leivestad T, Brekke IB, Flatmark A. Hartmann A, et al. Among authors: brekke ib. Transpl Int. 1992 Mar;5(1):15-8. doi: 10.1007/BF00337183. Transpl Int. 1992. PMID: 1580980

4

Renal transplantation from living donors mismatched for two HLA haplotypes.

Sødal G, Albrechtsen D, Berg KJ, Bondevik H, Brekke IB, Fauchald P, Jakobsen A, Talseth T, Thorsby E, Flatmark A. Sødal G, et al. Among authors: brekke ib. Transplant Proc. 1987 Feb;19(1 Pt 2):1509-10. Transplant Proc. 1987. PMID: 3079022 Clinical Trial. No abstract available.

5

Cancer risk after renal transplantation in the Norwegian transplant program.

Pfeffer PF, Hansen S, Leivestad T, Fauchald P, Brekke IB, Sødal G. Pfeffer PF, et al. Among authors: brekke ib. Transplant Proc. 1995 Feb;27(1):979-80. Transplant Proc. 1995. PMID: 7879253 No abstract available.

6

Anamnestic cancer: how long should the cancer-free interval be before renal transplantation?

Pfeffer PF, Leivestad T, Albrechtsen D, Fauchald P, Brekke IB. Pfeffer PF, et al. Among authors: brekke ib. Transplant Proc. 1997 Nov;29(7):3163. doi: 10.1016/s0041-1345(97)00826-9. Transplant Proc. 1997. PMID: 9365710 No abstract available.

7

Unrelated living donors in 141 kidney transplantations: a one-center study.

Foss A, Leivestad T, Brekke IB, Fauchald P, Bentdal O, Lien B, Pfeffer P, Sødal G, Albrechtsen D, Søreide O, Flatmark A. Foss A, et al. Among authors: brekke ib. Transplantation. 1998 Jul 15;66(1):49-52. doi: 10.1097/00007890-199807150-00008. Transplantation. 1998. PMID: 9679821

8

The role of HLA matching in renal transplantation: experience from one center.

Leivestad T, Reisaeter AV, Brekke IB, Vartdal F, Thorsby E. Leivestad T, et al. Among authors: brekke ib. Rev Immunogenet. 1999;1(3):343-50. Rev Immunogenet. 1999. PMID: 11256425

9

BMA 031 effectively reverses steroid-resistant rejection in renal transplants.

Pfeffer PF, Jakobsen A, Albrechtsen D, Sødal G, Brekke I, Bentdal O, Leivestad T, Fauchald P, Flatmark A. Pfeffer PF, et al. Transplant Proc. 1991 Feb;23(1 Pt 2):1099-100. Transplant Proc. 1991. PMID: 1989159 No abstract available.

10

Renal replacement therapy in the cyclosporine era: results of a national transplantation program.

Albrechtsen D, Berg KJ, Brekke I, Fauchald P, Jakobsen A, Sødal G, Talseth T, Leivestad T, Flatmark A. Albrechtsen D, et al. Transplant Proc. 1990 Feb;22(1):155-6. Transplant Proc. 1990. PMID: 2309295 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

111 results

Search Page